Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C and HIV Coinfection => Topic started by: Hep Editors on September 17, 2018, 11:08:23 am

Title: Taking Harvoni With Viread Appears Safe for the Kidneys
Post by: Hep Editors on September 17, 2018, 11:08:23 am

People who take Harvoni (ledipasvir/sofosbuvir) to treat hepatitis C virus (HCV) can apparently take it along with the antiretroviral (ARV) Viread (tenofovir disoproxil fumarate, or TDF) without posing a threat to their kidney health, Infectious Disease Advisor reports.

Viread is approved to treat both HIV and hepatitis B virus (HBV). The drug is included in the double-ARV combination tablet Truvada (tenofovir disoproxil fumarate/emtricitabine), which is approved for use as pre-exposure prophylaxis, or PrEP, against HIV. The drug is also included in the single-tablet HIV regimens:

Atripla (efavirenz/tenofovir disoproxil fumarate/emtricitabine)
Complera (rilpivirine/tenofovir disoproxil fumarate/emtricitabine)
Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate)
Symfi (efavirenz 600 mg/lamivudine/tenofovir disoproxil fumarate)

For more...
https://www.hepmag.com/article/taking-harvoni-viread-appears-safe-kidneys